"Designing Growth Strategies is in our DNA"

North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Monoclonal Antibodies, Antineoplastic, Hedgehog Pathway Inhibitors, and Others), By Route of Administration (Oral, Topical, and Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Forecast, 2021-2028

Region : North America | Format: PDF | Report ID: FBI106348

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. New Product Launches, Key Players
    2. Key Industry Developments Partnerships, Mergers, and Acquisitions
    3. Overview of Regulatory Scenario for the Approval of Drugs in the U.S.
    4. Impact of COVID 19 on the Market
  5. North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Monoclonal Antibodies
      2. Antineoplastic
      3. Hedgehog Pathway Inhibitors
      4. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
      3. Parenteral
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  6. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2020)
    3. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, Financials (based on availability))
      1. F. Hoffmann-La Roche Ltd.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      2. Merck & Co., Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      3. Sanofi
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      4. Eli Lilly and Company
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      5. Regeneron Pharmaceuticals Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      6. Bausch Health Companies Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      7. Sun Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      8. Amgen Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      9. LEO Pharma A/S
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
  7. Strategic Recommendations
Read Less

Table 01: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue (USD million) Forecast, by Country, 2017-2028

Table 02: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue (USD million) Forecast, By Drug Class, 2017-2028

Table 03: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue (USD million) forecast, by Route of Administration, 2017-2028

Table 04: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue (USD million) forecast, by Distribution Channel, 2017-2028

Figure 01: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Value (USD million), by Country, 2020 & 2028

Figure 02: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue Share (%), by Country, 2020

Figure 03: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue Share (%), by Drug Class, 2020

Figure 04: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue Share (%), by Route of Administration, 2020

Figure 05: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Revenue Share (%), by Distribution Channel, 2020

Figure 06: North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Share Analysis (%), By Company, 2020

  • Feb, 2022
  • 2020
  • 2017-2019
  • 122

    CHOOSE LICENSE TYPE

  • $3850
    $4850
    $6850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X